EP3423082
LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.3.2017EP published:
4.8.2021EP application number:
17710160.7
EPO information:
European Patent Register
Max expiry date:
2.3.2037
Title:
LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS
Timeline
Today
3.3.2017EP application
4.8.2021EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
RASMUSSEN, SørenAddress:
2880 Bagsværd, DK
Name:
KVIST, KajsaAddress:
2880 Bagsværd, DK
Priority
Number:
16158739Date:
4.3.2016Country:
EP
Number:
16173917Date:
10.6.2016Country:
EP
Number:
16001329Date:
13.6.2016Country:
EP
Number:
201715401651Date:
9.1.2017Country:
US
Classification
Categories:
A61K 38/26, A61P 3/10, A61P 7/12, A61P 9/00, A61P 9/04, A61P 9/10, A61P 13/12, A61P 43/00, A61K 47/02, A61K 47/10